Title:
INDOLINE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2010/150837
Kind Code:
A1
Abstract:
A therapeutic agent for hyperparathyroidism, secondary hyperparathyroidism, primary hyperparathyroidism, renal osteodystrophy, hypercalcemia or the like, which has a calcium sensing receptor activation activity and comprises a compound represented by general formula (I) [wherein R1 and R2 independently represent a hydrogen atom, a halogeno group, or the like; R3 and R4 independently represent a C1-C3 alkyl group; R5 represents a hydrogen atom, or the like; R6 represents a carboxyphenyl group, or the like; and R8, R9 and R10 independently represent a hydrogen atom, a halogeno group, a cyano group, or the like] or a pharmacologically acceptable salt thereof as an active ingredient.
Inventors:
EBISAWA MASAYUKI
SHINOZUKA TSUYOSHI
HASEGAWA TORU
NAITO SATORU
MARUMOTO SHINJI
FUKUSHIMA YASUO
KATO MIKIO
SHINOZUKA TSUYOSHI
HASEGAWA TORU
NAITO SATORU
MARUMOTO SHINJI
FUKUSHIMA YASUO
KATO MIKIO
Application Number:
PCT/JP2010/060704
Publication Date:
December 29, 2010
Filing Date:
June 24, 2010
Export Citation:
Assignee:
DAIICHI SANKYO CO LTD (JP)
EBISAWA MASAYUKI
SHINOZUKA TSUYOSHI
HASEGAWA TORU
NAITO SATORU
MARUMOTO SHINJI
FUKUSHIMA YASUO
KATO MIKIO
EBISAWA MASAYUKI
SHINOZUKA TSUYOSHI
HASEGAWA TORU
NAITO SATORU
MARUMOTO SHINJI
FUKUSHIMA YASUO
KATO MIKIO
International Classes:
C07D209/08; A61K31/404; A61K31/405; A61P3/14; A61P5/18; A61P19/08; A61P43/00; C07D209/26
Domestic Patent References:
| WO1998001417A1 | 1998-01-15 |
Foreign References:
| JPH07506380A | 1995-07-13 | |||
| JPH10513436A | 1998-12-22 |
Attorney, Agent or Firm:
ISHIBASHI Koki et al. (JP)
Kimiki Ishibashi (JP)
Kimiki Ishibashi (JP)
Download PDF: